SUMMARY Hemodynamic and metabolic studies were performed in 15 patients without heart disease (controls, group A), in 21 patients with typical stress-induced anginal pain but normal coronary and left ventricular angiograms (angina pectoris with normal arteriogram, group B), and in 10 patients with angiographically proved coronary artery disease (CAD, group C). Coronary dilatory capacity, determined by measuring total myocardial blood flow at rest and during maximal coronary vasodilatation (dipyridamole, 0.5 mg/kg i.v.), was markedly reduced in group B and C patients. In group B patients, left ventricular catheter biopsy specimens revealed no evidence of small-vessel disease, but did show histologic alterations of mitochondria. During atrial pacing, the control subjects showed no changes in myocardial lactate uptake, whereas in group B patients, myocardial lactate production occurred. In contrast to controls, patients in group B showed a significant decline in ejection fraction and circumferential fiber shortening during isometric exercise. These findings suggest that myocardial ischemia is the cause of angina pectoris in patients who have angina but normal coronary arteriograms.
THE PARADOX of patients suffering from typical stress-induced anginal pain who have normal coronary and left ventricular angiograms has been reported in recent studies.1'~3 The nature of this disease is unknown, and it has been also called syndrome X. 5 Myocardial ischemia that is caused by an abnormal affinity of hemoglobin for oxygen, coronary arterial spasm or occlusive disease of small coronary arteries not visualized by coronary arteriography have been suggested as possible causes of this syndrome. 4' 6, 14 To evaluate further patients who have angina pectoris but normal coronary arteriograms, the following studies were performed in addition to left ventricular and coronary angiography: (1) Coronary blood flow (CBF) was measured at rest and during dipyridamoleinduced coronary vasodilatation; (2) biopsy specimens were taken from left ventricular myocardium for microscopic evaluation of intramyocardial vessels and of myocardial cells; (3) myocardial lactate metabolism was studied at rest and during atrial pacing; and (4) left ventricular function was assessed during rest and during exercise. Group 
A -Controls
We studied 15 patients (10 males and five females) without detectable heart disease. These patients suffered from recurrent atypical chest pain that did not respond to nitrates, and showed a normal ECG, including exercise ECG. They were referred from the psychosomatic clinic for coronary arteriography to exclude an organic cause of the symptoms. Right-and left-heart catheterization revealed normal pressures. All patients of this group had normal coronary and left ventricular angiograms.
Group B -Angina Pectoris with Normal Arteriogram
Group B included 21 patients (15 males and six females) with typical stress-induced angina pectoris promptly relieved by nitroglycerin. None of these patients had valvular heart diseases, diabetes mellitus, arterial hypertension or collagen diseases.
Group C -Coronary Artery Disease Group C consisted of 10 patients (nine males and one female) with angiographically proved coronary artery disease (CAD) ( Hg) coronary blood flow (ml/ 100 g * min) Oxygen content was measured using Lex 02 Con analyzer. Myocardial oxygen consumption (MVO2) was calculated as MVO2 = arteriocoronary sinus content difference (ml/100 ml) X CBF (ml/100 g* min).
Transarterial Left Ventricular Endomyocardial Biopsy
Biopsy specimens of the 18 patients with angina pectoris and normal arteriograms (group B) were taken from left ventricular myocardium using King's college bioptome and the S. Thomas' shield24 and immediately fixed by immersion with 1.5% glutaraldehyde-1.5% formaldehyde mixture in 0.1 M phosphate buffer. The tissue was embedded and oriented in block in such a way that endocardium, Purkinje fibers, and myocardium could be clearly identified by light and electron microscopic analysis.
Myocardial Lactate Metabolism
In five patients in group A and eight patients in group B, arterial and coronary sinus blood samples were collected at rest, during atrial pacing (150 beats/min) and after administration of dipyridamole. Lactate was determined by a specific enzymatic method (monotest Boehringer). Myocardial net lactate metabolism was expressed in ,umol/100 g tissue * min and calculated as the product of simultaneously measured CBF and arterial-coronary sinus lactate difference.
Coronary and Left Ventricular Angiography Selective coronary arteriography was performed with multiple views of the right (at least three projections) and left (at least five projections) coronary arteries including hemiaxial projections. Pressures in the left ventricle were obtained by means of a fluidfilled catheter-pressure transducer system. Enddiastolic and end-systolic volumes, ejection fraction and mean velocity of circumferential fiber shortening were calculated from the monoplane angiogram in a 300 right anterior oblique projection using standard formulas. 25 Coronary Blood Flow CBF was 78.8 ml/100 g* min in control subjects (group A) and 74.3 ml/ 100 g * min in group B patients (NS; table 1). In group C, CBF was 85.4 ml/100 g * min, which was not different from that in group A.
After dipyridamole, however, maximal CBF in group B patients was markedly reduced, to approximately 50% of the value in controls, with maximal coronary flow rates of 300 ml/100 g,* min (p < 0.001; table 1, fig. 1 ). In group C, CBF was 166.4 ml/100 g * min, significantly lower than the value in controls (p < 0.001; table 1). Resting CR was 0.96 mm Hg/ml/100 g-min in controls and significantly increased, to l.l1 mm Hg/ml/ 100 g* mm,in group B patients (p < 0.02). In group C, CR did not differ from controls (0.94 mm Hg/ml/100 g * min). After dipyridamole, CR was 0.22 mm Hg/ml/100 g * min in controls, and it was significantly increased in group B (0.52 mm Hg/ml/100 g* min; p < 0.001; fig. 1 ) and group C (0.47 mm Hg/ml/100 g. min; p < 0.001; MVO2 during rest was 9.1 mi/100 g* min in controls, 9.3 ml/100 g min in group B (NS) and 10.0 ml/100 g * min in group C (NS). During coronary vasodilatation by dipyridamole, MVO2 increased in controls to 13.7 ml/100 g * min, but was unchanged in patients in group B (9.5 ml/l00 g* min; p < 0.001 coinpared with controls). In group C patients, MVO2 during dipyridamole was 13 fig. 2 ). The other cell organelles were normal, except for occasional. disturbances of Z bands (fig. 3A) . The arteriolar microvascular segments showed no pathologic changes, such as intimal proliferation, medial dissection or mural deposits. There was no thickening of the basal lamina ( fig. 2B) . The capillaries and venular segments had also a normal appearance.
Measurements of CBF and lactate metabolism at rest, during atrial pacing and after dipyridamole are given in table 3 and in figure 4 . In group B patients, atrial pacing produced a moderate increase of CBF, to about the same extent as the controls (115 and 108 ml/l00 g* min). CR was also comparable during atrial pacing in group A and group B. These groups, however, could be separated by studying lactate metabolism during atrial pacing: Group B patients showed lactate production, but controls did not Under resting conditions, ejection fraction and mean circumferential fiber shortening did not differ between controls and group B patients ( fig. 5 ). During isometric work by handgrip (one-third of maximal force for 4 minutes), group B patients showed significantly lower ejection fraction and circumferential fiber shortening compared with controls (p < 0.001).
Discussion
All group B patients in this study had typical stressinduced angina pectoris promptly relieved by nitroglycerin. Patients suffering from conditions such as collagen disease, arterial hypertension or diabetes mellitus, which may lead to microangiopathy, were excluded. Group B patients had normal coronary arteriograms, normal ventriculograms at rest, and the intracardiac pressures were within normal limits. The marked (-50%) reduction in coronary dilatory capacity could explain the stress-induced anginal pain, the pathologic exercise ECG test, the abnormal lactate metabolism during atrial pacing, and the abnormal response of the left ventricular function to the isometric exercise test. Patients with CAD but without previous myocardial infarction had a markedly reduced coronary dilatory capacity, most likely caused by the obstructive lesions of the larger epicardial arteries visible by coronary arteriography.
The reduction of coronary dilatory capacity in group B patients cannot be explained by obstructive lesions of the coronary arteries, and therefore, may be attributed to abnormalities of small intramyocardial vessels not visualized by coronary arteriography. 14 However, if this putative disease of small vessels were diffuse enough to produce anginal symptoms and to reduce coronary reserve by about 50%, structural changes would be expected in the biopsy specimens taken from the left ventricular myocardium. The myocardial biopsy specimens in our patients, however, showed only normal arterioles, metarterioles, capillaries and venules.
The range of analyzable small vessels is limited by technical and statistical difficulties, and vessels between about 40-200 p are neither accessible to light and electron microscopic examination nor to angiographic techniques. The lack of observed vascular damage, however, does not exclude abnormalities of the microvascular system and of the small arteries as the cause of reduced coronary dilatory would be expected to cause a high resting CBF, low oxygen extraction and high coronary venous oxygen content, which was not the case in our group B patients. In contrast, coronary arterial spasm, which is believed to cause variant angina, generally is neither stress-induced nor accompanied by reduced coronary dilatory capacity during the symptom-free interval. In no patient of group B did we observe typical ST elevation, either at rest or during exercise. An important finding in all patients of group B was a swelling of mitochondria combined with deposits of small myelin figures. These mitochondrial alterations may be interpreted as signs of hypoxia. This assumption may be supported by our observations in cases of lupus erythematosus, in which an extreme swelling of mitochondria and a large number of small myelin figures were present. Little is known about alterations of myocardial cells in ischemic heart disease. First investigations in patients with CAD29 showed mitochondrial alterations without further changes of myocardial cells. The distortion of Z bands may be at least partially interpreted as nonspecific changes due to the fixation and biopsy procedure, because a few Z-band abnormalities can be found in all biopsy specimens. The morphologic appearance of the myocardial cells does not allow these patients with angina pectoris and normal arteriograms to be defined as having "early cardiomyopathy," because no long-term follow-up studies are available. Patients of group B showed myocardial lactate production during atrial pacing, VCF Abbreviations: CBF = coronary blood flow; CR = coronary resistance; A = resting conditions; B atrial pacing (150 beats/min); C = dipyridamole (0.5 mg/kg).
probably because of regional perfusion abnormalities and ischemia.7 Other authors'0 30 did not observe perfusion abnormalities in patients with angina pectoris and normal coronary arteriograms. However, flow in the endomyocardial layers predominantly affected by stress-induced angina cannot be quantitated by any method. Group B patients had normal CBF under resting conditions, but it was significantly reduced after pharmacologic dilatation by dipyridamole. The drug is an almost selective dilatator of the coronary arteries31 and probably acts by influencing specific reactions of local metabolic regulation of CBF, possibly by interfering with the degradation of adenosine,32 which is believed to be a mediator substance between myocardial energy metabolism and coronary flow (local metabolic regulation of CBF). Our results are consistent with the hypothesis that the reduced coronary dilatory capacity in these patients with angina pectoris and normal coronary arteriograms may be the result of myocardial metabolic alterations either in transmitter substance formation or in alterations of the receptors for coronary vasodilatation.
